Related Experiment Video
Updated: Apr 15, 2026

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti ratti Infection
Published on: January 17, 2025
Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in
Abstract:
We describe a case of persistent strongyloidiasis complicated by recurrent meningitis, in a human T cell lymphotropic virus type 1 (HTLV-1) seropositive Peruvian migrant adult resettled in Italy. He was admitted with signs and symptoms of acute bacterial meningitis, reporting four other meningitis episodes in the past 6 years, with an etiological diagnosis of Escherichia coli and Enterococcus faecium in two cases. He had been previously treated with several antihelmintic regimens not including ivermectin, without eradication of strongyloidiasis, and he had never been tested for HTLV before. During the described episode, the patient was treated for meningitis with broad-spectrum antibiotic therapy and 200 μg/kg/dose oral ivermectin once daily on day 1, 2, 15 and 16 with full recovery and no further episodes of meningitis. The presented case underlines several critical points concerning the management of poorly known neglected diseases such as strongyloidiasis and HTLV infection in low-endemic areas. Despite several admissions for meningitis and strongyloidiasis, the parasitic infection was not adequately treated and the patient was not previously tested for HTLV. The supply of ivermectin and the choice of treatment scheme was challenging since ivermectin is not approved in Italy and there are no standardized guidelines for the treatment of severe strongyloidiasis in HTLV seropositive subjects.
Insights
Persistent strongyloidiasis in an HTLV-1 positive migrant caused recurrent meningitis. Ivermectin treatment successfully resolved both infections, highlighting challenges in managing neglected diseases in non-endemic areas.
Area of Science:
- Infectious Diseases
- Tropical Medicine
- Clinical Case Study
Background:
- Persistent strongyloidiasis is a neglected tropical disease.
- Human T-cell lymphotropic virus type 1 (HTLV-1) infection can exacerbate parasitic infections.
- Recurrent meningitis poses significant health risks.
Observation:
- A case of persistent strongyloidiasis complicated by recurrent meningitis in an HTLV-1 seropositive Peruvian migrant in Italy.
- Previous treatments with antihelmintics failed to eradicate strongyloidiasis.
- The patient experienced multiple episodes of bacterial meningitis (Escherichia coli, Enterococcus faecium).
Findings:
- Successful treatment of recurrent meningitis and persistent strongyloidiasis was achieved with a specific oral ivermectin regimen.
- Ivermectin is not approved in Italy, and standardized treatment guidelines for severe strongyloidiasis in HTLV-1 positive individuals are lacking.
- The case highlights diagnostic and therapeutic challenges in managing neglected diseases in low-endemic settings.
Implications:
- This case underscores the importance of considering and adequately treating neglected tropical diseases, like strongyloidiasis, especially in immunocompromised individuals or those with co-infections like HTLV-1.
- It highlights the need for updated clinical guidelines and improved access to essential medicines like ivermectin for treating severe parasitic infections.
- Effective management requires a multidisciplinary approach, particularly in regions where these diseases are not commonly encountered.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
Cytomegalovirus Disease

